The Terpenoid Team
Raymond J. Hohl
Dr. Hohl is a co-founder and the president of Terpenoid Therapeutics. He is a Professor of Internal Medicine and Pharmacology and the holder of the Holden Family Chair at the University of Iowa. He has clinical expertise and is board certified in Internal Medicine, Medical Oncology, Hematology, and Clinical Pharmacology. Dr. Hohl joined the University of Iowa in 1991 and from 1999 to 2005 he served as the Director of the Division of Hematology, Oncology and Blood & Marrow Transplantation. Since then he has been Associate Chair of the Department of Internal Medicine and Associate Director for Translational Research at the Holden Comprehensive Cancer Center. From 2003 through 2006 he served as a member of the Board of Directors for the American Society for Clinical Pharmacology and Therapeutics. He has received research support from the Roy J. Carver Charitable Trust, the National Institutes of Health, and the Leukemia & Lymphoma Society. At Iowa he directs a Carver Research Program of Excellence and the Roland W. Holden Family Program in Experimental Cancer Therapeutics. He is an Associate Editor for the Journal of Clinical Pharmacology and Therapeutics and a member of the editorial advisory board for the journal Lipids. Dr. Hohl received a BS in Biochemistry from the University of Illinois, an MD from Rush University, and a PhD in Pharmacology from Rush University. 
David F. Wiemer
Dr. Wiemer is a co-founder of Terpenoid Therapeutics. He is a Professor of Chemistry and Pharmacology and chair of the Department of Chemistry at the University of Iowa. Dr. Wiemer has been a professor in the Department of Chemistry since 1978, and a professor in the Pharmacology Department since 2004. From 2001 to 2002 he served as Interim Associate Dean for Academic Affairs in the Graduate College. In 1993 he received the University of Iowa Collegiate Teaching Award and in 2003 received the Regent's Award for Faculty Excellence. He has received research support from the National Institutes of Health, the National Science Foundation, the U.S. Army Medical and Materiel Command-Breast Cancer Research Program, the Roy J. Carver Charitable Trust, the Leukemia & Lymphoma Society, and the Children's Tumor Foundation. Dr. Wiemer received a BS in Chemistry from Marquette University and a PhD in Organic Chemistry from the University of Illinois. He held a postdoctoral fellowship in Organic Chemistry at Cornell University. 
Jeffrey D. Neighbors
Dr. Neighbors is a co-founder of Terpenoid Therapeutics and a Senior Scientist. He is currently a part-time Research Scientist at the University of Iowa, and a part-time Senior Scientist at Terpenoid Therapeutics, Inc. He was supported by an Institutional Cancer Research Training Grant in 2005 and was also awarded a predoctoral fellowship from the US Army Medical Research and Materiel Command Breast Cancer Research Program from 2002 to 2004. He has received research support from the National Institutes of Health. Dr. Neighbors received a BS in Chemistry from the University of Iowa and a PhD in Organic Chemistry from the University of Iowa. He has completed a period of postdoctoral studies in the labs of Professor Raymond Hohl (Pharmacology), and Professor David Wiemer (Chemistry). 
Andrew J. Wiemer
Dr. Wiemer is a co-founder of Terpenoid Therapeutics. He previously worked with Dr. Hohl as a research assistant and graduate student. Dr. Wiemer is currently a postdoctoral fellow at the University of Wisconsin. He has received postdoctoral research support from the National Institutes of Health. Dr. Wiemer received a BS in Biology from the University of Notre Dame, an MS in Biochemistry from Colorado State University, and a PhD in Molecular Biology from the University of Iowa.